This inventor holds 1 USPTO granted patent. Top assignee: Kali-Chemie Pharma Gmbh. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Derk Hamminga: Innovator in Pharmaceutical Chemistry
Introduction
Derk Hamminga is a notable inventor based in Leusden, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that have potential therapeutic applications.
Latest Patents
Hamminga holds a patent for "1,7-fused 1H-indole-2-carboxylic acid-N-(1,4-benzodiazepin-3-yl)amides." This patent encompasses compounds corresponding to a specific formula, where R¹ can represent hydrogen, lower alkyl, or cycloalkylalkyl with 4-7 carbon atoms. His work in this area demonstrates his commitment to advancing pharmaceutical science.
Career Highlights
Derk Hamminga is currently associated with Kali-Chemie Pharma GmbH, where he continues to explore innovative solutions in drug development. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Hamminga has collaborated with notable colleagues, including Harald Waldeck and Werner Benson. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Derk Hamminga's contributions to pharmaceutical chemistry through his patent and collaborations highlight his role as an innovator in the field. His work continues to inspire advancements in drug development and therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile